Professor Callaway’s contribution to women’s and newborn health in the Australian population, includes: 1) National guidelines: She led the development of national clinical practice guidelines for the management of pre-gestational diabetes and screening for gestational diabetes (GDM); and, 2) Translation of Research into Practice including research regarding breastfeeding and insulin therapy in women with type 1 diabetes underpins the practical advice provided in national guidelines.
She has also led significant improvement into health systems, services, policy, programs, specifically writing, implementing and evaluating local and state-wide clinical practice guidelines (Obesity, Diabetes, Growth Restriction, Obstetric Cholestasis, Hypertension, Thromboembolism, COVID-19 and pregnancy). She also led the simplification of GDM screening processes during the pandemic in Qld, adopted Australia wide and internationally, with publications in press. She has >20 local, inter/national presentations about compassionate clinical care for larger bodied women (based on her research about childhood trauma), with consistent feedback that these profoundly affect clinician attitudes and clinical practice.
She has also led significant improvement into health systems, services, policy, programs, specifically writing, implementing and evaluating local and state-wide clinical practice guidelines (Obesity, Diabetes, Growth Restriction, Obstetric Cholestasis, Hypertension, Thromboembolism, COVID-19 and pregnancy). She also led the simplification of GDM screening processes during the pandemic in Qld, adopted Australia wide and internationally, with publications in press. She has >20 local, inter/national presentations about compassionate clinical care for larger bodied women (based on her research about childhood trauma), with consistent feedback that these profoundly affect clinician attitudes and clinical practice.
